WaBio.com is now WashingtonLifeScience.com
WashingtonLifeScience.com (formerly known as WaBio.com) has been renamed to better reflect the broad diversity of the
rapidly growing biotechnology, medical device, nanotechnology, pharmaceutical and related industry in
the state of Washington.
More importantly, WashingtonLifeScience.com is now part of a specialized national network of state- and province-based biotechnology,
medical device, and life science sites that includes more than 5,000 biotechnology, medical device, pharmaceutical companies,
non-profit research institutions, universities and supporting service sector companies across the U.S. and Canada.
WashingtonLifeScience.com clients can now cost effectively advertise their job openings, events, facility availability
and other services at the state level, Pacific Northwest level or nationwide for the same low rate.
 More...
Destination Washington
Are you considering a move to Washington? Relocating your business to
Washington? Starting a company? Or just interested in Washington?
This section will answer many of your questions regarding the life science industry in Washington, the state's
economy, tax structure and cost of living, education, transportation, climate, recreational opportunities, history,
industry resources, and more.
More...
|
|
|
Local News...
Free News Release Posting & Archiving Service
- Wyeth names Michael Kamarck President, Technical Operations & Product Supply Wyeth announced that Michael Kamarck, Ph.D., 57, has been promoted to President, Technical Operations & Product Supply (TO&PS). Dr. Kamarck will be responsible for all aspects of technical operations and product supply for Wyeth.
Wyeth November 20, 2008
- Wyeth declares preferred stock dividend At a meeting of the Board of Directors of Wyeth, a dividend of fifty cents ($0.50) per share on the outstanding shares of Preferred Stock was declared payable on January 2, 2009 to stockholders of record at the close of business on December 12, 2008.
Wyeth November 20, 2008
- OSU-developed technology licensed to Home Dialysis Plus Home Dialysis Plus (HD+), a developer of advanced home hemodialysis devices, announces the signing of a licensing agreement with Oregon State University for exclusive global use of MECS technology in blood filtration and water treatment for dialysis.
Oregon State University November 20, 2008
- Tibotec begins enrollment in Europe for Phase III trial of telaprevir Tibotec BVBA announced that it has begun enrolling patients in its phase III study of telaprevir (VX-950), an investigational protease inhibitor (PI), in patients with chronic genotype 1 hepatitis C virus (HCV) for whom the current standard treatment has not been successful.
Johnson & Johnson November 20, 2008
- Tibotec presents interim findings for TMC435, an investigational genotype 1 HepC treatment New clinical data show antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed by Tibotec BVBA for the treatment of chronic hepatitis C virus (HCV) infection.
Johnson & Johnson November 20, 2008
More... | Submit News Release | National News
|
New Job Postings...
The Recruiter’s Studio: People, Careers, Conversations
More... |
Job Advertising...
|
New Facilities Available...
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
Free Event Posting Service
 More... |
Submit Event |
Event Advertising...
|
|
Learn About Washington's BioHistory
Why is there a biotechnology industry in Washington? Will the industry continue
to grow in Washington? What do other states have? Each state has a unique story
that explains why a given industry has developed in a specific region and not in others.
Through Washington BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industries in the state of Washington.
More...
BioEvolution Posters
More...
November is American Diabetes Month
Diabetes is a leading cause of kidney failure, blindness and amputations, and a major cause of heart
disease and stroke. Nearly 24 million Americans have diabetes, and about one quarter (or 5.7 million)
of them don't know that they have the disease. Millions more are at risk of developing diabetes.
Diabetes is a costly disease associated with serious complications and premature death. It is a major
cause of heart disease and stroke and a leading cause of leg and foot amputations unrelated to injury,
kidney failure, and new blindness in adults.
More...
BioFact
(1917) - Stem rust attacks the U.S. wheat crop, destroying more than two million bushels and forcing Herbert Hoover's Food Administration to declare two wheatless days a week.
It's a Small World
|
| |
Organic Cells
| |
Science Quote
"We know very little, and yet it is astonishing that we know so much, and still more astonishing that so little knowledge can give us so much power."
| - |
Bertrand Russell, English philosopher
|
|
(1872-1970)
|
|
